Hey Bio. I recognize you from the ZLCS board....
Anyway, I'd say half on imuc and half on nwbo.
I see nwbo as better in the short term-- in phase 3, ridiculously low valuation, low float (only 13 mil shares), so share price could rocket up rapidly at a moment's notice.
I see imuc as a great long-term play--deep pipeline, well-designed trials, and I can almost guarantee will be bought out by big pharma one day. But it's still in phase 2.
Either one of these will be a 10-20 bagger, so if you bet half on each yoh only need one to succeed.